COMBINING SUPPLY CHAIN MODELLING CONCEPTS AND LIFE CYCLE ASSESSMENT FOR SUSTAINABLE MEDICINE SUPPLY CHAIN RECONFIGURATION

The COVID-19 health contingency has highlighted the reliance of several countries on India and China to meet their medication demands, prompting them to explore alternative solutions. This research project aims to investigate the synergies between Supply Chain Management (SCM) and Life Cycle Assessment (LCA) to propose a hybrid approach for reconfiguring the Sustainable Medicine Supply Chain (SMSC). The authors suggest utilizing LCA simulations to evaluate the impact of different SMSC configurations on global climate change, thereby providing decision-makers with an objective basis for their considerations. The findings of this study demonstrate that manufacturing paracetamol pills in France not only helps alleviate the current scarcity of this medication in the country but also presents a more sustainable option in terms of global warming. By simulating two different SMSC configurations and assessing their respective impacts on global warming, this research provides valuable insights for decision-makers. These results offer an empirical foundation to guide informed decision-making processes.